Marc Boutin, VP & COO, Discusses Importance of an FDA Benefit-Risk Balance

Sunday, June 3, 2012

Marc Boutin, NHC's Executive Vice President and Chief Operating Officer, discusses the importance of an FDA benefit-risk balance that meets the needs of patients on BioCentury TV.